Movement Disorders Clinical Trials

Find Movement Disorders Clinical Trials Near You

Italian Translation and Validation of the GIDS-PD Scale for Parkinson's Disease

Status: Recruiting
Location: See all (5) locations...
Study Type: Observational
SUMMARY

This study aims to translate and validate the Gastrointestinal Dysfunction Scale for Parkinson's Disease (GIDS-PD) into Italian to enable the assessment of gastrointestinal symptoms in Italian-speaking patients with Parkinson's disease. The psychometric properties of the translated instrument will be evaluated through a multi-phase process involving translation/back-translation, pre-testing, and large-scale validation across multiple Italian centers

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥18 years;

• Diagnosis of PD according to the Movement Disorder Society (MDS) diagnostic criteria (Postuma RB et al., 2015);

• Italian-native patients or patients that understand Italian correctly at least;

• Participants mentally and physically able to understand and sign the informed consent form.

Locations
Other Locations
Italy
Fondazione IRCCS Istituto Neurologico Carlo Besta
RECRUITING
Milan
Ospedale Universitario Luigi Sacco, Milano, Italia
NOT_YET_RECRUITING
Milan
Unità Parkinson e Disturbi del Movimento, Dipartimento di Neuroscienze(DNS), Università di Padova, Padova, Italia
NOT_YET_RECRUITING
Padova
Centro per le Malattie Neurodegenerative e l'Invecchiamento Cerebrale, Università degli Studi di Bari Aldo Moro presso la Pia Fondazione Card. G. Panico, Tricase, Italia
NOT_YET_RECRUITING
Tricase
Unità di Neurologia, Divisione Malattia di Parkinson e Disturbi del Movimento, Dipartimento di Neuroscienze, Biomedicina e Scienze del Movimento, Università di Verona, Italia
NOT_YET_RECRUITING
Verona
Time Frame
Start Date: 2025-10-08
Estimated Completion Date: 2028-11
Participants
Target number of participants: 190
Related Therapeutic Areas
Sponsors
Leads: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

This content was sourced from clinicaltrials.gov